| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91013af35af964dae788966a58661aab |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
| filingDate |
2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b7d47f64726f94f0141120d34276d53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02130401849939fc8b68f8a434f5c63f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059876ffc46bd019be9bf09849319b54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb70d1b7f47ce5c4dfba14b770689372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcef2a79cd2e4d43d3fd49c94e8d0866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c622bcc2bdb53230cda3ebb22ffe33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d3c40fb9e9162004045fea645c5f032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_817c9e87f4bbb6c5272190cec0e81e5e |
| publicationDate |
2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020129521-A1 |
| titleOfInvention |
Method and composition for treating epilepsy |
| abstract |
A method of treating a subject suffering from epilepsy includes administering an effective amount of a cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof to the subject. A pharmaceutical composition includes the cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof as active ingredient, one or more antiepileptic compounds, and a pharmaceutically acceptable excipient. |
| priorityDate |
2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |